Physician profile
John A Kirby
NPI 1164502126
$937.59
in general payments reported to CMS, 2019-2025
15 companies · $24.33 in 2025
The $24.33 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $133 · 2025: $24.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $225.64 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $162.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $126.07 | 2019 | |
| Sunovion Pharmaceuticals INC. | $107.63 | 2019 | |
| Astellas Pharma US INC | $94.38 | 2019 | |
| Pfizer INC. | $50.64 | 2019 | |
| Novo Nordisk INC | $43.02 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $26.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.85 | 2019 | |
| Sanofi Pasteur INC. | $25.52 | 2019 | |
| Tandem Diabetes Care, INC. | $24.33 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $13.86 | 2019 | |
| Allergan, INC. | $11.70 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kirby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.